[HTML][HTML] Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance

AE Tuomisto, MJ Mäkinen… - World journal of …, 2019 - ncbi.nlm.nih.gov
Systemic inflammation is a marker of poor prognosis preoperatively present in around 20%-
40% of colorectal cancer patients. The hallmarks of systemic inflammation include an …

Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature

S Sanduleanu, CMC le Clercq, E Dekker, GA Meijer… - Gut, 2015 - gut.bmj.com
Objective Interval colorectal cancers (interval CRCs), that is, cancers occurring after a
negative screening test or examination, are an important indicator of the quality and …

Impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test

M Zorzi, U Fedeli, E Schievano, E Bovo, S Guzzinati… - Gut, 2015 - gut.bmj.com
Objective Colorectal cancer (CRC) screening programmes based on the guaiac faecal
occult blood test (gFOBT) reduce CRC-specific mortality. Several studies have shown higher …

[HTML][HTML] Difference in performance of fecal immunochemical tests with the same hemoglobin cutoff concentration in a nationwide colorectal cancer screening program

TH Chiang, SL Chuang, SLS Chen, HM Chiu, AMF Yen… - Gastroenterology, 2014 - Elsevier
Background & Aims We investigated whether 2 quantitative fecal immunochemical tests
(FITs) with the same cutoff concentration of fecal hemoglobin perform equivalently in …

How a faecal immunochemical test screening programme changes annual colorectal cancer incidence rates: an Italian intention-to-screen study

L Bucchi, S Mancini, F Baldacchini, A Ravaioli… - British Journal of …, 2022 - nature.com
Background This study aimed to evaluate the effectiveness of a biennial faecal
immunochemical test (FIT) screening programme in reducing annual colorectal cancer …

Interval colorectal cancer incidence among subjects undergoing multiple rounds of fecal immunochemical testing

M van der Vlugt, EJ Grobbee, PMM Bossuyt, A Bos… - Gastroenterology, 2017 - Elsevier
Background & Aims Among subjects screened for colorectal cancer (CRC) by the guaiac
fecal occult blood test, interval cancers develop in 48% to 55% of the subjects. Data are …

Participant-related risk factors for false-positive and false-negative fecal immunochemical tests in colorectal cancer screening: systematic review and meta-analysis

CM de Klerk, LM Vendrig, PM Bossuyt… - Official journal of the …, 2018 - journals.lww.com
OBJECTIVES: Colorectal cancer (CRC) screening using fecal immunochemical tests (FIT)
may reduce CRC-related mortality but its effectiveness is influenced by the limited accuracy …

Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: longitudinal follow-up of a Taiwanese population-based colorectal cancer …

LS Chen, AMF Yen, SYH Chiu, CS Liao… - The lancet …, 2011 - thelancet.com
Background Despite widespread use of the immunochemical faecal occult blood test
(iFOBT), little is known about the subsequent risk of developing colorectal neoplasia for …

Optimizing the colorectal cancer screening programme using faecal immunochemical test (FIT) in Flanders, Belgium from the “interval cancer” perspective

TN Tran, M Peeters, S Hoeck, G Van Hal… - British Journal of …, 2022 - nature.com
Background Interval cancer (IC) is a critical issue in colorectal cancer (CRC) screening. We
identified factors associated with ICs after faecal immunochemical test (FIT) screening and …

Colonoscopy later than 270 days in a fecal immunochemical test-based population screening program is associated with higher prevalence of colorectal cancer

M Zorzi, C Hassan, G Capodaglio, M Baracco… - …, 2020 - thieme-connect.com
Background Colorectal cancer (CRC) screening programs based on fecal immunochemical
testing (FIT) generate substantial pressure on colonoscopy capacity in Europe. Thus, a …